Literature DB >> 18463317

Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells.

Ryousuke Satou1, Romer A Gonzalez-Villalobos, Kayoko Miyata, Naro Ohashi, Akemi Katsurada, L Gabriel Navar, Hiroyuki Kobori.   

Abstract

Augmented intrarenal ANG II stimulates IL-6, which contributes to renal injury. The expression of intrarenal angiotensinogen (AGT) is enhanced by increased intrarenal ANG II in human renin/human AGT double transgenic mice. ANG II also augments AGT expression in hepatocytes and cardiac myocytes. However, the mechanisms underlying AGT augmentation by ANG II and the contribution of IL-6 to this system are poorly understood. This study was performed in human renal proximal tubular epithelial cells (HRPTECs) to test the hypothesis that IL-6 contributes to the upregulation of AGT expression by ANG II. Human kidney-2 (HK-2) cells, immortalized HRPTECs, were incubated with 10(-7) M ANG II and/or 10 ng/ml IL-6 for up to 24 h. AGT mRNA and protein expressions were measured by real-time RT-PCR and ELISA, respectively. The activities of NF-kappaB and STAT3 were evaluated by Western blotting and EMSA. Stimulation with either ANG II or IL-6 did not significantly alter AGT mRNA or protein expression. In contrast, costimulation with ANG II and IL-6 significantly increased AGT mRNA and protein expressions (1.26 +/- 0.10 and 1.16 +/- 0.13 over control, respectively). Olmesartan, an ANG II type 1 receptor blocker, and an IL-6 receptor antibody individually inhibited this synergistic effect. NF-kappaB was also activated by costimulation with ANG II and IL-6. Phosphorylation and activity of STAT3 were increased by stimulation with IL-6 alone and by costimulation. The present study indicates that IL-6 plays an important role in ANG II-mediated augmentation of AGT expression in human renal proximal tubular cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463317      PMCID: PMC2494515          DOI: 10.1152/ajprenal.00047.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  40 in total

Review 1.  Tissue renin angiotensin systems.

Authors:  Richard N Re
Journal:  Med Clin North Am       Date:  2004-01       Impact factor: 5.456

2.  Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.

Authors:  Aicha Saadane; Sophia Masters; Joseph DiDonato; Jingfeng Li; Melvin Berger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

3.  Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney.

Authors:  Marta Ruiz-Ortega; Mónica Ruperez; Oscar Lorenzo; Vanesa Esteban; Julia Blanco; Sergio Mezzano; Jesus Egido
Journal:  Kidney Int Suppl       Date:  2002-12       Impact factor: 10.545

4.  Steroid responsiveness of renal epithelial cells. Dissociation of transrepression and transactivation.

Authors:  Simone de Haij; Ian M Adcock; Astrid C Bakker; Sam J P Gobin; Mohamed R Daha; Cees van Kooten
Journal:  J Biol Chem       Date:  2002-10-31       Impact factor: 5.157

5.  Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation.

Authors:  M Jamaluddin; T Meng; J Sun; I Boldogh; Y Han; A R Brasier
Journal:  Mol Endocrinol       Date:  2000-01

Review 6.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

7.  Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6.

Authors:  C T Sherman; A R Brasier
Journal:  Mol Endocrinol       Date:  2001-03

8.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

9.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Authors:  Michelle A Blaskovich; Jiazhi Sun; Alan Cantor; James Turkson; Richard Jove; Saïd M Sebti
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 10.  Vascular inflammation and the renin-angiotensin system.

Authors:  Allan R Brasier; Adrian Recinos; Mohsen S Eledrisi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

View more
  42 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Does interleukin 6 contribute to renal hemodynamic changes during angiotensin II-dependent hypertension?

Authors:  Michael J Ryan
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

3.  Tumor necrosis factor-{alpha}: a reno-protective cytokine? Focus on "Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells".

Authors:  Akira Takaguri; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2010-07-21       Impact factor: 4.249

4.  Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Romer A Gonzalez-Villalobos; Julie R Ingelfinger; L Gabriel Navar; Hiroyuki Kobori
Journal:  FASEB J       Date:  2012-02-01       Impact factor: 5.191

Review 5.  Inflammatory cytokines regulate renal sodium transporters: how, where, and why?

Authors:  Allison E Norlander; Meena S Madhur
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

Review 6.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

7.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

8.  Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review.

Authors:  Congqing Wu; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  N Am J Med Sci (Boston)       Date:  2011-10-01

9.  Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats.

Authors:  Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

Review 10.  Renal generation of angiotensin II and the pathogenesis of hypertension.

Authors:  Jorge F Giani; Tea Janjulia; Brian Taylor; Ellen A Bernstein; Kandarp Shah; Xiao Z Shen; Alicia A McDonough; Kenneth E Bernstein; Romer A Gonzalez-Villalobos
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.